Several companies released their second quarter 2025 financial results and operational updates. Vivos Therapeutics reported revenue of $3.8 million, a gross profit of $2.1 million, and an operating loss of $4.9 million. The company also completed the acquisition of the Sleep Center of Nevada to expand its obstructive sleep apnea treatment offerings. OS Therapies and I-Mab also provided business updates alongside their Q2 financial results. Futu Holdings, the parent company of Moomoo, reported a 69.7% year-over-year increase in total revenues to $676.6 million, surpassing estimates of $616 million. Its net income rose 105% year-over-year to $339 million. The company also saw growth in key metrics including funded accounts, brokerage accounts, users, and client assets, with client assets reaching $124.7 billion, up 68% year-over-year. Fly-E Group announced its first quarter fiscal year 2026 financial results, while CollPlant Biotechnologies released its Q2 2025 financial results and corporate update. iQIYI also announced its second quarter 2025 financial results.